The American journal of cardiology
-
A prolonged rate-corrected QT interval (QTc) may be associated with an increased risk of developing ventricular arrhythmias and sudden death, particularly in patients with the hereditary long QT syndrome (LQTS), myocardial ischemia, or antiarrhythmic medication toxicity. It is known that there are some patients with LQTS who sometimes have a borderline or normal QTc (< or = 0.45 second). Although the QTc has been the standard measurement of ventricular repolarization, it includes both depolarization and repolarization and may not always be a sensitive indicator of the type of repolarization abnormalities seen in LQTS. ⋯ The JTc identified 85% of patients affected with LQTS compared with only 58% identified using only the QTc as a marker for the syndrome. The JTc is a more specific measurement of ventricular repolarization than the QTc by eliminating QRS duration variability. It appears to be a more sensitive predictor of repolarization abnormalities, and may be helpful in identifying patients with LQTS who have borderline or normal QTc measurements on resting electrocardiograms.
-
Comparative Study Clinical Trial
Usefulness of a third Holter lead for detection of myocardial ischemia.
Two-channel ambulatory electrocardiographic (ECG) monitoring is a useful method for detecting transient myocardial ischemia in patients with coronary artery disease. However, the monitoring of only 2 leads may fail to detect a significant number of ischemic episodes. In this study, the additional diagnostic value of a third bipolar chest lead was evaluated by recording a simultaneous 12-lead electrocardiogram and a 3-channel ambulatory electrocardiogram during exercise testing in 223 patients (aged 63 +/- 10 years) with proved or suspected coronary disease. ⋯ CM5 was the single lead with the highest sensitivity (89%) in detecting myocardial ischemia. The addition of CM3 to CM5 increased sensitivity to 91%, and the addition of an inferior lead to CM5 increased sensitivity to 94%, particularly improving the detection of isolated inferior myocardial ischemia. The combination of all 3 ambulatory ECG leads had a sensitivity of 96%, an improvement of only 2% compared with the best combination of 2 leads (i.e., CM5 +/- inferior lead).(ABSTRACT TRUNCATED AT 250 WORDS)
-
In 17 patients (14 men and 3 women aged 69 +/- 10 years), a transvenous pacemaker was implanted before (8 patients), following (7 patients), or simultaneously (2 patients) with the insertion of a transvenous defibrillator. Indications included malignant ventricular arrhythmias and symptomatic bradycardia in all patients. All patients had structural heart disease. ⋯ During a mean follow-up of 11 +/- 6 months, 2 patients died because of pump failure and 7 patients received defibrillator therapy for ventricular arrhythmias. No significant complications were noted. Successful concomitant implantation of transvenous pacemakers and defibrillators was thus accomplished in 17 patients, which suggests that insertion of a second transvenous device can be safely accomplished.
-
Randomized Controlled Trial Comparative Study Clinical Trial
Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
No prospective studies have compared sotalol and amiodarone during electropharmacologic testing. The purpose of this prospective, randomized study was to compare the electrophysiologic effects of sotalol and amiodarone in patients with coronary artery disease and sustained monomorphic ventricular tachycardia (VT). Patients with coronary artery disease and sustained monomorphic VT inducible by programmed stimulation were randomly assigned to receive either sotalol (n = 17) or amiodarone (n = 17). ⋯ There were no significant differences in the effects of sotalol and amiodarone on the ventricular effective refractory period. In patients with coronary artery disease, amiodarone and sotalol are similar in efficacy in the treatment of VT as assessed by electropharmacologic testing. The effects of the 2 drugs on ventricular refractoriness are similar, but amiodarone slows VT to a greater extent than sotalol.